首页> 美国卫生研究院文献>other >Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic l-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra pars reticulata
【2h】

Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic l-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra pars reticulata

机译:成年大鼠多巴胺神经元的单侧6-羟基多巴胺损伤和亚慢性I-DOPA给药改变了纹状体神经元不同亚群和黑质中的水泡GABA转运蛋白的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The loss of dopamine neurons combined or not with the subsequent administration of levodopa (l-DOPA) in patients with Parkinson’s disease or in experimental models of the disease results in altered GABAergic signaling throughout the basal ganglia, including the striatum and the substantia nigra, pars reticulata. However, the molecular mechanisms involved in altered GABA neurotransmission remain poorly understood. In order to be released from synaptic vesicles, newly synthesized GABA is transported from the cytosol into synaptic vesicles by a vesicular GABA transporter. The objective of this study was to examine the hypothesis that expression of the vesicular GABA transporter vGAT is altered in the unilateral 6-hydroxydopamine model of Parkinson’s disease. Our results provide evidence that a unilateral 6-hydroxydopamine lesion results in increased and decreased vGAT mRNA levels in striatopallidal and striatonigral neurons, respectively. These two subsets of neurons were identified by the co-expression or lack of co-expression of preproenkephalin, a marker of striatopallidal neurons, using double-labeling in situ hybridization histochemistry. Such changes occurred in the striatum ipsilateral to the 6-hydroxydopamine lesion and were paralleled by decreased vGAT protein levels in the SNr. On the other hand, the subchronic systemic administration of l-DOPA increased vGAT mRNA levels in preproenkephalin-negative neurons on the side ipsilateral and, to a lesser extent, the side contralateral to the 6-hydroxydopamine lesion. Systemic l-DOPA also increased vGAT protein levels in the ipsi- and contralateral SNr. As a whole, the results provide original evidence that vGAT expression is altered in the 6-hydroxydopamine model of Parkinson’s disease. They also suggest that the behavioral effects induced by a subchronic administration of l-DOPA to 6-hydroxydopamine-lesioned rats involve an increase in the vesicular release of GABA by striatonigral neurons.
机译:在帕金森氏病患者或该疾病的实验模型中,多巴胺神经元的丧失与随后给予左旋多巴(l-DOPA)的结合与否与否,导致整个基底神经节(包括纹状体和黑质)的GABA能信号传递发生改变网状。然而,涉及改变的GABA神经传递的分子机制仍然知之甚少。为了从突触小泡中释放,新合成的GABA通过小泡GABA转运蛋白从细胞质中转运到突触小泡中。这项研究的目的是检验以下假设:在帕金森氏病的单侧6-羟基多巴胺模型中,水泡GABA转运蛋白vGAT的表达发生了改变。我们的结果提供了证据,表明单侧6-羟基多巴胺损伤分别导致纹状体顶神经和纹状体神经元中的vGAT mRNA水平升高和降低。使用双标记原位杂交组织化学方法通过前脑啡肽原(一种纹状体腹膜神经元的标志物)的共表达或不共表达来识别这两个神经元子集。这种变化发生在6-羟基多巴胺损伤的同侧纹状体中,并且与SNr中的vGAT蛋白水平降低相平行。另一方面,对l-DOPA的亚慢性全身性给药会增加前脑啡肽原阴性神经元在同侧的一侧,而在较小程度上,对6-羟基多巴胺病变的一侧则增加了vGAT mRNA水平。全身性I-DOPA也增加了同侧和对侧SNr中的vGAT蛋白水平。总体而言,该结果提供了原始证据,证明帕金森氏病的6-羟基多巴胺模型中vGAT表达发生了改变。他们还表明,亚慢性给予1-羟基多巴胺损伤的大鼠1-DOPA诱导的行为效应涉及纹状体顶神经元的GABA囊泡释放增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号